GO:0006222 UMP biosynthetic process: Pyrimidine Nucleotide Synthesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006222 (UMP biosynthetic process) describes the chemical reactions and pathways that result in the formation of uridine monophosphate (UMP), the parent pyrimidine ribonucleotide from which all other pyrimidine nucleotides are derived.
• UMP biosynthesis supplies the pyrimidine building blocks needed for RNA, DNA, UDP-sugars, CDP-lipids and activated nucleotide-sugar donors, making it essential for proliferation and metabolism.
• Key enzymes include CAD, DHODH, UMPS, CMPK2 and UCK2, which together convert bicarbonate, glutamine and aspartate into UMP and recycle pyrimidine nucleosides.
• Cancer cells frequently upregulate pyrimidine synthesis and salvage to support rapid proliferation; UCK2 upregulation is associated with unfavorable prognosis in hepatocellular carcinoma.
• UMP-derived metabolites participate in signaling and cell-state control, including an UMP-vimentin axis that influences colorectal cancer dissemination.
• CRISPR knockout, point-mutation, knock-in and overexpression models, combined with metabolic and transcriptomic profiling, are powerful tools to dissect UMP biosynthetic process genes.
Description
Uridine monophosphate (UMP) is the central pyrimidine ribonucleotide from which all other pyrimidine nucleotides are synthesized. The Gene Ontology term GO:0006222, UMP biosynthetic process, captures the chemical reactions and pathways that result in the formation of UMP. This process is fundamental to nucleic acid synthesis, nucleotide-sugar metabolism and cellular proliferation, and its dysregulation has been linked to cancer, antiviral responses and metabolic reprogramming. Understanding UMP biosynthesis is therefore essential for researchers studying nucleotide metabolism, cell growth and disease mechanisms.
UMP biosynthetic process At A Glance
| GO ID | GO:0006222 |
|---|---|
| GO term | UMP biosynthetic process |
| Ontology | biological_process |
| Synonym | UMP anabolism; UMP biosynthesis; UMP formation; UMP synthesis |
| Major function | Synthesis of uridine monophosphate, the parent pyrimidine ribonucleotide |
| Key enzymes | CAD, DHODH, UMPS, CMPK2, UCK2, NME family |
| Pathway context | De novo pyrimidine biosynthesis and pyrimidine salvage |
| Disease relevance | Cancer proliferation, antiviral innate immunity, metabolic disorders |
| Research methods | CRISPR KO/point mutation/knock-in/overexpression, metabolomics, RNA-seq, Ribo-seq |
What Is GO:0006222?
GO:0006222 (UMP biosynthetic process) is defined by QuickGO as the chemical reactions and pathways resulting in the formation of UMP, uridine monophosphate. In practical terms, it encompasses both the de novo route that builds the pyrimidine ring from small precursors such as bicarbonate, glutamine and aspartate, and the salvage-like steps that regenerate UMP from uridine or uracil. The term is a biological process and is synonymous with UMP anabolism, UMP biosynthesis, UMP formation and UMP synthesis.
Why Is UMP biosynthetic process Important in Cell Biology?
UMP biosynthetic process is important because UMP is the obligate precursor of all pyrimidine nucleotides, including CTP, dTTP and UDP-sugars, which are required for RNA and DNA synthesis, protein glycosylation and lipid metabolism. Cells that proliferate rapidly, such as cancer cells and activated immune cells, depend on robust pyrimidine synthesis, and perturbations in this pathway can impair growth or trigger metabolic stress. Moreover, pyrimidine nucleotides contribute to antiviral innate immunity and to signaling networks that influence cell migration and dissemination. Consequently, GO:0006222 sits at the intersection of cancer metabolism, immunometabolism and antiviral defense.
• Provides the pyrimidine scaffold for RNA, DNA and nucleotide-sugar biosynthesis.
• Supports rapid proliferation in cancer and activated immune cells.
• Links to redox balance and tumor growth through HES4-regulated pyrimidine synthesis.
• Contributes to antiviral innate immunity via CMPK2-dependent nucleotide metabolism.
• Participates in an UMP-vimentin axis that influences colorectal cancer dissemination.
• Is a target for antimetabolite and anticancer drug development.
• Can be studied with CRISPR KO, point mutation, knock-in and overexpression models.
• Interfaces with nucleoside transport and salvage pathways in plants and other organisms.
• Relevant to viral RNA synthesis strategies that depend on nucleotide availability.
• Provides biomarkers such as UCK2 expression for prognosis in hepatocellular carcinoma.
What Happens During UMP biosynthetic process?
De novo pyrimidine ring assembly
In simple terms: The cell builds the pyrimidine ring from scratch using small molecules.
The de novo pathway begins with the formation of carbamoyl phosphate and its condensation with aspartate to form dihydroorotate, a reaction sequence catalyzed by the multifunctional enzyme CAD. Dihydroorotate is then oxidized by DHODH to orotate, which is subsequently converted to UMP by UMPS. This route consumes bicarbonate, glutamine and aspartate and is tightly coupled to mitochondrial respiration through DHODH.
Salvage and interconversion to UMP
In simple terms: The cell can also recycle preformed uridine or uracil to make UMP.
In addition to de novo synthesis, cells can generate UMP through salvage pathways. Uridine kinase (UCK2) phosphorylates uridine to UMP, while CMPK2 (cytidine monophosphate kinase 2) phosphorylates CMP and UMP to their diphosphate forms, feeding into the pyrimidine nucleotide pool. These salvage reactions are especially important when de novo synthesis is limited or when nucleosides are supplied exogenously.
Compartmentalization and metabolic channeling
In simple terms: Different steps of UMP synthesis occur in different parts of the cell.
Pyrimidine biosynthesis is compartmentalized: CAD is cytosolic, DHODH is anchored to the inner mitochondrial membrane, and UMPS is cytosolic. This spatial organization allows efficient channeling of intermediates and links pyrimidine synthesis to mitochondrial electron transport. Compartmentalized branched-chain amino acid metabolism can also influence UMP availability and downstream vimentin dynamics in colorectal cancer cells.
UMP as a precursor for other pyrimidines
In simple terms: UMP is converted into other pyrimidine nucleotides needed for many cellular processes.
Once formed, UMP is phosphorylated to UDP and UTP, which can be aminated to CTP or deoxygenated to dUDP and dTTP. UDP also serves as a carrier for sugars in glycosylation reactions. Thus, UMP biosynthetic process feeds a broad network of nucleotide-dependent pathways, including RNA synthesis, DNA replication and protein glycosylation.
Regulation by redox and signaling
In simple terms: The pathway is turned up or down depending on the cell's needs and stress status.
UMP synthesis is regulated by nutrient availability, redox balance and oncogenic signaling. HES4 supports redox balance and pyrimidine synthesis to promote tumor growth. Palmitic acid promotes antiviral innate immunity via ZDHHC20-mediated CMPK2 palmitoylation, linking lipid metabolism to pyrimidine nucleotide production. These examples illustrate how UMP biosynthetic process is integrated with cellular stress and immune responses.
Key Genes Involved in GO:0006222 UMP biosynthetic process
The following genes and proteins are central to UMP biosynthetic process and its regulation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAD | Multifunctional enzyme catalyzing the first steps of de novo pyrimidine synthesis | Target for metabolic inhibitors and CRISPR KO studies |
| DHODH | Mitochondrial enzyme converting dihydroorotate to orotate | Linked to respiration and pyrimidine synthesis; drug target |
| UMPS | Converts orotate to UMP | Essential for de novo UMP synthesis; knockout causes pyrimidine auxotrophy |
| CMPK2 | Phosphorylates CMP/UMP to diphosphates; palmitoylated in antiviral immunity | Regulator of pyrimidine pools and innate immunity |
| UCK2 | Phosphorylates uridine to UMP in salvage pathway | Upregulated in hepatocellular carcinoma; prognostic marker |
| HES4 | Transcription factor supporting redox balance and pyrimidine synthesis | RNAi screens identify as regulator of tumor growth |
| NME1/2 | Nucleoside diphosphate kinases interconverting nucleotides | Maintain nucleotide pools for UMP-derived pathways |
| ZDHHC20 | Palmitoyltransferase modifying CMPK2 | Links lipid metabolism to antiviral pyrimidine metabolism |
| Vimentin | Cytoskeletal protein influenced by UMP axis | Implicated in colorectal cancer dissemination |
| BCAA metabolism enzymes | Compartmentalized branched-chain amino acid metabolism | Orchestrates UMP-vimentin axis in colorectal cancer |
| Nucleoside transporters | Facilitate uptake of uridine and other nucleosides | Important for salvage UMP synthesis |
| RNA-dependent RNA polymerases | Use UMP-containing nucleotides for viral RNA synthesis | Model for nucleotide availability in infection |
| Ribonucleotidyl transferases | Add nucleotides to RNA ends | Use UMP-derived substrates |
| Chondrocyte metabolic enzymes | Support nucleotide metabolism in joint tissue | Relevant to osteoarthritis models |
| Pyrimidine salvage enzymes | Recycle nucleosides to UMP | Targets for antiviral and anticancer strategies |
How Is UMP biosynthetic process Regulated?
UMP biosynthetic process is regulated at multiple levels. Nutrient availability, especially glutamine and aspartate, controls flux through CAD and DHODH. Redox balance influences pyrimidine synthesis, as HES4 supports this pathway to maintain tumor growth. Lipid signaling can modify CMPK2 via palmitoylation, enhancing antiviral innate immunity. In addition, nucleoside transport and salvage enzymes such as UCK2 adjust UMP levels in response to extracellular nucleoside supply. These regulatory layers ensure that pyrimidine production matches cellular demand for RNA, DNA and nucleotide-sugar synthesis.
UMP biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UCK2 | Hepatocellular carcinoma prognosis | CRISPR knockout or overexpression in liver cancer cell lines |
| HES4 | Tumor growth and redox balance | RNAi/CRISPR screens in cancer cells |
| CMPK2 | Antiviral innate immunity | Palmitoylation-deficient point mutants in immune cells |
| CAD/DHODH | Pyrimidine synthesis in cancer metabolism | Metabolic flux analysis with CRISPR KO |
| Vimentin | Colorectal cancer dissemination | UMP-vimentin axis perturbation in organoids |
UMP biosynthetic process in cancer
Cancer cells reprogram metabolism to support rapid proliferation, and pyrimidine synthesis is frequently upregulated. UCK2 upregulation is associated with unfavorable prognosis in hepatocellular carcinoma, suggesting that salvage UMP synthesis contributes to tumor aggressiveness. HES4 supports redox balance and pyrimidine synthesis, promoting tumor growth in RNAi screens. In colorectal cancer, compartmentalized branched-chain amino acid metabolism orchestrates an UMP-vimentin axis that influences dissemination. These findings position UMP biosynthetic process as a potential therapeutic target in oncology.
UMP biosynthetic process and antiviral immunity
Pyrimidine nucleotides are essential for antiviral innate immunity. Palmitic acid promotes antiviral innate immunity via ZDHHC20-mediated CMPK2 palmitoylation, which enhances CMPK2 function and pyrimidine nucleotide production. This illustrates how UMP-related metabolism can be modulated by lipid signals to strengthen host defense. Viruses also depend on nucleotide availability for RNA synthesis, as seen in protein-primed picornavirus RNA synthesis and RNA-specific ribonucleotidyl transferases.
UMP biosynthetic process in metabolic and joint disorders
Nucleotide metabolism is relevant beyond cancer and infection. iPSC-conditioned medium mitigates the adverse effects of osteoarthritic synovial fluid on chondrocyte cultures, highlighting metabolic crosstalk in joint tissue. Nucleoside transport and associated metabolism are also important in plants, indicating conserved roles for UMP-related pathways across organisms. These examples suggest that UMP biosynthetic process may contribute to diverse physiological and pathological states.
From UMP biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is CAD required for de novo UMP synthesis? | CRISPR knockout of CAD in cancer cell lines |
| Does a point mutation in CMPK2 affect palmitoylation? | Point-mutation knock-in of CMPK2 in immune cells |
| Can UCK2 overexpression drive pyrimidine salvage? | Overexpression of UCK2 in hepatocellular carcinoma cells |
| How does DHODH inhibition affect respiration? | DHODH knockout or inhibitor treatment in mitochondria-competent cells |
| Does HES4 regulate pyrimidine synthesis? | RNAi or CRISPR knockout of HES4 followed by metabolomics |
| Can tagged UMPS reveal localization? | Knock-in of fluorescent tag at UMPS locus |
How to Study the UMP biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Targeted metabolomics | UMP and pyrimidine nucleotide levels | Quantify pathway output after CRISPR perturbation |
| Isotope tracing | Flux through de novo synthesis | Determine carbon/nitrogen sources for UMP |
| RNA-seq | Transcriptional changes | Identify genes co-regulated with UMP synthesis |
| Ribo-seq | Translation efficiency | Detect post-transcriptional regulation of pathway enzymes |
| Proteomics | Protein interactions and modifications | Study CMPK2 palmitoylation and complex formation |
| Live-cell imaging | Enzyme localization | Track UMPS/DHODH compartmentalization |
| CRISPR screens | Gene essentiality and pathway dependencies | Identify regulators of UMP biosynthetic process |
Metabolomics and flux analysis
Targeted metabolomics and isotope tracing can quantify UMP and downstream pyrimidine nucleotides, revealing flux through de novo and salvage pathways. These methods are essential to confirm that genetic perturbations of CAD, DHODH, UMPS or UCK2 alter UMP biosynthetic process.
Transcriptomics and RNA-seq
RNA-seq can identify transcriptional changes in pyrimidine synthesis genes following CRISPR knockout or overexpression. For example, HES4 depletion alters expression programs linked to redox balance and pyrimidine synthesis. RNA-seq also helps contextualize UCK2 upregulation in hepatocellular carcinoma.
Ribo-seq and translation profiling
Ribo-seq measures translation efficiency of mRNAs encoding UMP biosynthetic enzymes, revealing post-transcriptional control. This is particularly useful when metabolic flux changes are not explained by transcript levels alone.
Imaging and proteomics
Fluorescent tagging of UMPS or DHODH enables live-cell imaging of enzyme localization. Proteomics can identify interaction partners and post-translational modifications, such as CMPK2 palmitoylation by ZDHHC20.
How CRISPR Can Be Used to Study GO:0006222 UMP biosynthetic process
Knockout
CRISPR knockout of CAD, DHODH, UMPS or UCK2 can abolish or reduce UMP biosynthetic process, causing pyrimidine auxotrophy and growth defects. Such models are used to test pathway dependency in cancer cells and to validate metabolic targets.
Point Mutation
Point mutations can dissect catalytic residues or regulatory modifications. For example, mutation of CMPK2 palmitoylation sites can test whether ZDHHC20-mediated palmitoylation is required for antiviral innate immunity.
Knock-in
Knock-in of fluorescent or affinity tags at endogenous loci enables real-time tracking of UMP biosynthetic enzymes. Tagged UMPS or DHODH knock-in cells allow imaging of compartmentalization and interaction dynamics.
Overexpression
Overexpression of UCK2 or other salvage enzymes can enhance UMP synthesis and pyrimidine pools, modeling the upregulation seen in hepatocellular carcinoma and other cancers. Overexpression models help test whether increased UMP synthesis drives proliferation or drug resistance.
How EDITGENE Supports UMP biosynthetic process Research
Researchers studying UMP biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in pyrimidine synthesis, cancer growth or antiviral immunity. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations, from knockout to knock-in, to support mechanistic and translational studies.
Contact EDITGENE today to design your custom CRISPR model for UMP biosynthetic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| UPRT Knockout HEK293 Cell Line | EDJ-KQ9585 | Human | 139596 | Details Get a Quote |
| UCKL1 Knockout HEK293 Cell Line | EDJ-KQ11999 | Human | 54963 | Details Get a Quote |
| UPRT Knockout HCT 116 Cell Line | EDJ-KQ35148 | Human | 139596 | Details Get a Quote |
| UPRT Knockout A-549 Cell Line | EDJ-KQ36412 | Human | 139596 | Details Get a Quote |
| UPRT Knockout HeLa Cell Line | EDJ-KQ36414 | Human | 139596 | Details Get a Quote |
| UCKL1 Knockout HeLa Cell Line | EDJ-KQ39328 | Human | 54963 | Details Get a Quote |
| UCKL1 Knockout A-549 Cell Line | EDJ-KQ40576 | Human | 54963 | Details Get a Quote |
| UCKL1 Knockout HCT 116 Cell Line | EDJ-KQ40577 | Human | 54963 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records
Frequently Asked Questions About UMP biosynthetic process
What is UMP biosynthetic process?
UMP biosynthetic process (GO:0006222) is the set of chemical reactions and pathways that result in the formation of uridine monophosphate, the parent pyrimidine ribonucleotide.
What genes are involved in UMP biosynthetic process?
Key genes include CAD, DHODH, UMPS, CMPK2 and UCK2, which catalyze de novo synthesis and salvage reactions to produce UMP.
Why is UMP important for cells?
UMP is the precursor for all pyrimidine nucleotides needed for RNA, DNA and nucleotide-sugar synthesis, making it essential for proliferation and metabolism.
How is UMP biosynthetic process regulated?
It is regulated by nutrient availability, redox balance and signaling pathways, including HES4-dependent redox control and CMPK2 palmitoylation.
Is UMP biosynthetic process linked to cancer?
Yes, upregulation of pyrimidine synthesis and salvage enzymes such as UCK2 is associated with tumor growth and poor prognosis in hepatocellular carcinoma.
What diseases are associated with UMP biosynthetic process?
Cancer, antiviral immunity and metabolic or joint disorders have been linked to pyrimidine nucleotide metabolism.
How can I study UMP biosynthetic process in the lab?
CRISPR knockout, point mutation, knock-in and overexpression models combined with metabolomics, RNA-seq and Ribo-seq are commonly used.
What is the role of CMPK2 in UMP metabolism?
CMPK2 phosphorylates CMP and UMP to diphosphates and is regulated by palmitoylation, linking lipid metabolism to antiviral innate immunity.
What is the UMP-vimentin axis?
It is a metabolic signaling axis in colorectal cancer where UMP availability influences vimentin dynamics and tumor dissemination.
Can CRISPR screens identify UMP pathway regulators?
Yes, RNAi and CRISPR screens have identified regulators such as HES4 that support pyrimidine synthesis and tumor growth.
Conclusion
GO:0006222 (UMP biosynthetic process) is a central metabolic pathway that supplies the pyrimidine nucleotides required for nucleic acid synthesis, glycosylation and cellular proliferation. Its dysregulation is implicated in cancer, antiviral immunity and metabolic disorders, making it a compelling area for mechanistic and translational research. By combining CRISPR-based genetic models with metabolic and transcriptomic profiling, researchers can dissect the causal roles of UMP pathway genes and identify new therapeutic opportunities.
References
- 1. Ji F et al.. 2026. Compartmentalized branched-chain amino acid metabolism orchestrates colorectal cancer dissemination via an UMP-vimentin axis.. Cell Metab 38(4):794-811.e8 PMID: 41653924
- 2. He J et al.. 2024. RNAi screens identify HES4 as a regulator of redox balance supporting pyrimidine synthesis and tumor growth.. Nat Struct Mol Biol 31(9):1413-1425 PMID: 38769389
- 3. Wang Y et al.. 2026. Palmitic Acid Promotes Antiviral Innate Immunity via ZDHHC20-Mediated CMPK2 Palmitoylation.. Adv Sci (Weinh) 13(37):e75209 PMID: 42011944
- 4. Möhlmann T et al.. 2010. Nucleoside transport and associated metabolism.. Plant Biol (Stuttg) 12 Suppl 1:26-34 PMID: 20712618
- 5. Paul AV et al.. 2015. Initiation of protein-primed picornavirus RNA synthesis.. Virus Res 206:12-26 PMID: 25592245
- 6. Martin G et al.. 2007. RNA-specific ribonucleotidyl transferases.. RNA 13(11):1834-49 PMID: 17872511
- 7. Rosochowicz MA et al.. 2025. iPSC-conditioned medium mitigates the adverse effects of osteoarthritic synovial fluid on chondrocyte cultures.. Biochem Biophys Res Commun 777:152336 PMID: 40652816
- 8. Yu S et al.. 2019. UCK2 upregulation might serve as an indicator of unfavorable prognosis of hepatocellular carcinoma.. IUBMB Life 71(1):105-112 PMID: 30304569